Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Jul 18;283(6285):173–178. doi: 10.1136/bmj.283.6285.173

A hitch-hiker's guide to the galaxy of adrenoceptors.

G M Lees
PMCID: PMC1506742  PMID: 6114769

Full text

PDF
173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson A. A., Lees G. M. Investigation of occurrence of tolerance to bronchodilator drugs in chronically pretreated guinea-pigs. Br J Pharmacol. 1976 Mar;56(3):331–338. doi: 10.1111/j.1476-5381.1976.tb07647.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berthelsen S., Pettinger W. A. A functional basis for classification of alpha-adrenergic receptors. Life Sci. 1977 Sep 1;21(5):595–606. doi: 10.1016/0024-3205(77)90066-2. [DOI] [PubMed] [Google Scholar]
  3. Carlsson E., Dahlöf C. G., Hedberg A., Persson H., Tångstrand B. Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 1977 Nov;300(2):101–105. doi: 10.1007/BF00505039. [DOI] [PubMed] [Google Scholar]
  4. Cavero I., Roach A. G. The pharmacology of prazosin, a novel antihypertensive agent. Life Sci. 1980 Oct 27;27(17):1525–1540. doi: 10.1016/0024-3205(80)90561-5. [DOI] [PubMed] [Google Scholar]
  5. Chatterjee K., Parmley W. W. Vasodilator therapy for chronic heart failure. Annu Rev Pharmacol Toxicol. 1980;20:475–512. doi: 10.1146/annurev.pa.20.040180.002355. [DOI] [PubMed] [Google Scholar]
  6. Conolly M. E., Greenacre J. K. The beta-adrenoceptor of the human lymphocyte and human lung parenchyma. Br J Pharmacol. 1977 Jan;59(1):17–23. doi: 10.1111/j.1476-5381.1977.tb06971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Docherty J. R., McGrath J. C. A comparison of pre- and post-junctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Evidence for two types of post-junctional alpha-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol. 1980 Jun;312(2):107–116. doi: 10.1007/BF00569718. [DOI] [PubMed] [Google Scholar]
  8. Drew G. M., Whiting S. B. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol. 1979 Oct;67(2):207–215. doi: 10.1111/j.1476-5381.1979.tb08668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Furchgott R. F. Pharmacological characterization of receptors: its relation to radioligand-binding studies. Fed Proc. 1978 Feb;37(2):115–120. [PubMed] [Google Scholar]
  10. Greenacre J. K., Conolly M. E. Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and patients with phaeochromocytoma: studies in vivo. Br J Clin Pharmacol. 1978 Mar;5(3):191–197. doi: 10.1111/j.1365-2125.1978.tb01623.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hoffman B. B., De Lean A., Wood C. L., Schocken D. D., Lefkowitz R. J. Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci. 1979 May 7;24(19):1739–1745. doi: 10.1016/0024-3205(79)90061-4. [DOI] [PubMed] [Google Scholar]
  12. Hoffman B. B., Lefkowitz R. J. Alpha-adrenergic receptor subtypes. N Engl J Med. 1980 Jun 19;302(25):1390–1396. doi: 10.1056/NEJM198006193022504. [DOI] [PubMed] [Google Scholar]
  13. Hoffman B. B., Lefkowitz R. J. Radioligand binding studies of adrenergic receptors: new insights into molecular and physiological regulation. Annu Rev Pharmacol Toxicol. 1980;20:581–608. doi: 10.1146/annurev.pa.20.040180.003053. [DOI] [PubMed] [Google Scholar]
  14. Jauernig R. A., Moulds R. F., Shaw J. The action of prazosin in human vascular preparations. Arch Int Pharmacodyn Ther. 1978 Jan;231(1):81–89. [PubMed] [Google Scholar]
  15. Johnsson G. Use of beta-adrenoreceptor blockers in combination with beta-stimulators in patients with obstructive lung disease. Drugs. 1976;11(Suppl 1):171–177. doi: 10.2165/00003495-197600111-00035. [DOI] [PubMed] [Google Scholar]
  16. Kebabian J. W., Calne D. B. Multiple receptors for dopamine. Nature. 1979 Jan 11;277(5692):93–96. doi: 10.1038/277093a0. [DOI] [PubMed] [Google Scholar]
  17. Kukreja S. C., Hargis G. K., Bowser E. N., Henderson W. J., Fisherman E. W., Williams G. A. Role of adrenergic stimuli in parathyroid hormone secretion in man. J Clin Endocrinol Metab. 1975 Mar;40(3):478–481. doi: 10.1210/jcem-40-3-478. [DOI] [PubMed] [Google Scholar]
  18. Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
  19. Langer S. Z., Dubocovich M. L. Subsensitivity of presynaptic alpha-adrenoceptors after exposure to noradrenaline. Eur J Pharmacol. 1977 Jan 7;41(1):87–88. doi: 10.1016/0014-2999(77)90377-6. [DOI] [PubMed] [Google Scholar]
  20. Langer S. Z. Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol. 1977 Aug;60(4):481–497. doi: 10.1111/j.1476-5381.1977.tb07526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lefkowitz R. J. Beta-adrenergic receptors: recognition and regulation. N Engl J Med. 1976 Aug 5;295(6):323–328. doi: 10.1056/NEJM197608052950607. [DOI] [PubMed] [Google Scholar]
  22. Lefkowitz R. J. Identification and regulation of alpha- and beta-adrenergic receptors. Fed Proc. 1978 Feb;37(2):123–129. [PubMed] [Google Scholar]
  23. Lefkowitz R. J., Limbird L. E., Mukherjee C., Caron M. G. The beta-adrenergic receptor and adenylate cyclase. Biochim Biophys Acta. 1976 Apr 13;457(1):1–39. doi: 10.1016/0304-4157(76)90012-5. [DOI] [PubMed] [Google Scholar]
  24. Malik K. U. Prostaglandins--modulation of adrenergic nervous system. Fed Proc. 1978 Feb;37(2):203–207. [PubMed] [Google Scholar]
  25. McGrath M. A., Shepherd J. T. Histamine and 5-hydroxytryptamine-inhibition of transmitter release mediated by H2- and 5-hydroxytryptamine receptors. Fed Proc. 1978 Feb;37(2):195–198. [PubMed] [Google Scholar]
  26. Minneman K. P., Molinoff P. B. Classification and quantitation of beta-adrenergic receptor subtypes. Biochem Pharmacol. 1980 May 15;29(10):1317–1323. doi: 10.1016/0006-2952(80)90424-4. [DOI] [PubMed] [Google Scholar]
  27. Moulds R. J., Jauernig R. A. Mechanism of prazosin collapse. Lancet. 1977 Jan 22;1(8004):200–201. doi: 10.1016/s0140-6736(77)91808-6. [DOI] [PubMed] [Google Scholar]
  28. Nathanson J. A. beta-Adrenergic-sensitive adenylate cyclase in choroid plexus: properties and cellular localization. Mol Pharmacol. 1980 Sep;18(2):199–209. [PubMed] [Google Scholar]
  29. Purdy R. E., Krueger C. G., Young S. Evidence for nonclassical alpha adrenoceptor blockade by prazosin in isolated rabbit blood vessels. Life Sci. 1980 Dec 8;27(23):2187–2195. doi: 10.1016/0024-3205(80)90383-5. [DOI] [PubMed] [Google Scholar]
  30. Shepherd J. T. Alteration in activity of vascular smooth muscle by local modulation of adrenergic transmitter release. Introductory remarks. Fed Proc. 1978 Feb;37(2):179–180. [PubMed] [Google Scholar]
  31. Shepherd J. T., Lorenz R. R., Tyce G. M., Vanhoutte P. M. Acetylcholine--inhibition of transmitter release from adrenergic nerve terminals mediated by muscarinic receptors. Fed Proc. 1978 Feb;37(2):191–194. [PubMed] [Google Scholar]
  32. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  33. Taylor M. W., Gaddie J., Murchison L. E., Palmer K. N. Metabolic effects of oral salbutamol. Br Med J. 1976 Jan 3;1(6000):22–22. doi: 10.1136/bmj.1.6000.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Williams L. T., Lefkowitz R. J., Watanabe A. M., Hathaway D. R., Besch H. R., Jr Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem. 1977 Apr 25;252(8):2787–2789. [PubMed] [Google Scholar]
  35. Williams L. T., Snyderman R., Lefkowitz R. J. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest. 1976 Jan;57(1):149–155. doi: 10.1172/JCI108254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zimmerman B. G. Actions of angiotensin on adrenergic nerve endings. Fed Proc. 1978 Feb;37(2):199–202. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES